nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2C—obesity	0.108	0.406	CbGaD
Cyproheptadine—DRD2—obesity	0.0886	0.335	CbGaD
Cyproheptadine—Cyclobenzaprine—Benzphetamine—obesity	0.0757	0.388	CrCrCtD
Cyproheptadine—HTR2A—obesity	0.0685	0.259	CbGaD
Cyproheptadine—SLC6A2—Diethylpropion—obesity	0.067	0.194	CbGbCtD
Cyproheptadine—Diphenylpyraline—Benzphetamine—obesity	0.0629	0.323	CrCrCtD
Cyproheptadine—Cyclizine—Benzphetamine—obesity	0.0564	0.289	CrCrCtD
Cyproheptadine—SLC6A2—Sibutramine—obesity	0.0508	0.147	CbGbCtD
Cyproheptadine—SLC6A2—Phendimetrazine—obesity	0.0508	0.147	CbGbCtD
Cyproheptadine—SLC6A2—Benzphetamine—obesity	0.0385	0.111	CbGbCtD
Cyproheptadine—SLC6A2—Phentermine—obesity	0.0385	0.111	CbGbCtD
Cyproheptadine—SLC6A2—Phenylpropanolamine—obesity	0.0367	0.106	CbGbCtD
Cyproheptadine—SLC6A2—Bupropion—obesity	0.0327	0.0947	CbGbCtD
Cyproheptadine—SLC6A2—Methamphetamine—obesity	0.0308	0.089	CbGbCtD
Cyproheptadine—CHRM3—muscle of abdomen—obesity	0.0031	0.127	CbGeAlD
Cyproheptadine—SLC6A2—sympathetic nervous system—obesity	0.00252	0.103	CbGeAlD
Cyproheptadine—SLC6A2—autonomic nervous system—obesity	0.0017	0.0692	CbGeAlD
Cyproheptadine—HTR2A—sympathetic nervous system—obesity	0.00152	0.0619	CbGeAlD
Cyproheptadine—HTR2A—vagus nerve—obesity	0.00147	0.06	CbGeAlD
Cyproheptadine—HTR2A—autonomic nervous system—obesity	0.00102	0.0416	CbGeAlD
Cyproheptadine—UGT1A3—digestive system—obesity	0.000986	0.0403	CbGeAlD
Cyproheptadine—UGT1A3—endocrine gland—obesity	0.000815	0.0333	CbGeAlD
Cyproheptadine—UGT1A3—liver—obesity	0.000735	0.03	CbGeAlD
Cyproheptadine—HTR1A—hindbrain—obesity	0.000721	0.0294	CbGeAlD
Cyproheptadine—DRD2—hindbrain—obesity	0.000651	0.0266	CbGeAlD
Cyproheptadine—SLC6A2—respiratory system—obesity	0.000436	0.0178	CbGeAlD
Cyproheptadine—HTR2A—hindbrain—obesity	0.000429	0.0175	CbGeAlD
Cyproheptadine—CHRM2—cardiovascular system—obesity	0.000415	0.017	CbGeAlD
Cyproheptadine—HTR2B—adrenal cortex—obesity	0.000412	0.0168	CbGeAlD
Cyproheptadine—DRD2—respiratory system—obesity	0.000398	0.0162	CbGeAlD
Cyproheptadine—Tachycardia—Phenylpropanolamine—obesity	0.000381	0.00446	CcSEcCtD
Cyproheptadine—CHRM1—cardiovascular system—obesity	0.000378	0.0154	CbGeAlD
Cyproheptadine—HTR2B—cardiovascular system—obesity	0.000376	0.0154	CbGeAlD
Cyproheptadine—Vision blurred—Diethylpropion—obesity	0.000376	0.0044	CcSEcCtD
Cyproheptadine—Oedema—Phentermine—obesity	0.000374	0.00438	CcSEcCtD
Cyproheptadine—Tremor—Diethylpropion—obesity	0.000373	0.00437	CcSEcCtD
Cyproheptadine—Increased appetite—Orlistat—obesity	0.00037	0.00433	CcSEcCtD
Cyproheptadine—Nasal congestion—Sibutramine—obesity	0.000369	0.00432	CcSEcCtD
Cyproheptadine—Agitation—Diethylpropion—obesity	0.000366	0.00429	CcSEcCtD
Cyproheptadine—Hypotension—Phenylpropanolamine—obesity	0.000365	0.00427	CcSEcCtD
Cyproheptadine—Tachycardia—Phentermine—obesity	0.000365	0.00427	CcSEcCtD
Cyproheptadine—Increased appetite—Sibutramine—obesity	0.000358	0.00419	CcSEcCtD
Cyproheptadine—Leukopenia—Diethylpropion—obesity	0.000357	0.00418	CcSEcCtD
Cyproheptadine—Diarrhoea—Methamphetamine—obesity	0.000356	0.00417	CcSEcCtD
Cyproheptadine—Insomnia—Phenylpropanolamine—obesity	0.000353	0.00414	CcSEcCtD
Cyproheptadine—Palpitations—Diethylpropion—obesity	0.000352	0.00412	CcSEcCtD
Cyproheptadine—Agitation—Cimetidine—obesity	0.000349	0.00408	CcSEcCtD
Cyproheptadine—Somnolence—Phenylpropanolamine—obesity	0.000347	0.00407	CcSEcCtD
Cyproheptadine—Euphoric mood—Bupropion—obesity	0.000347	0.00406	CcSEcCtD
Cyproheptadine—Convulsion—Diethylpropion—obesity	0.000345	0.00404	CcSEcCtD
Cyproheptadine—Dizziness—Methamphetamine—obesity	0.000344	0.00403	CcSEcCtD
Cyproheptadine—Diarrhoea—Benzphetamine—obesity	0.000343	0.00402	CcSEcCtD
Cyproheptadine—Leukopenia—Cimetidine—obesity	0.00034	0.00397	CcSEcCtD
Cyproheptadine—Insomnia—Phentermine—obesity	0.000338	0.00396	CcSEcCtD
Cyproheptadine—HTR1A—cardiovascular system—obesity	0.000337	0.0138	CbGeAlD
Cyproheptadine—Constipation—Phenylpropanolamine—obesity	0.000334	0.00391	CcSEcCtD
Cyproheptadine—Photosensitivity—Bupropion—obesity	0.000334	0.00391	CcSEcCtD
Cyproheptadine—Dizziness—Benzphetamine—obesity	0.000332	0.00388	CcSEcCtD
Cyproheptadine—HTR2B—adipose tissue—obesity	0.000332	0.0135	CbGeAlD
Cyproheptadine—Dyspepsia—Phentermine—obesity	0.000329	0.00385	CcSEcCtD
Cyproheptadine—Headache—Methamphetamine—obesity	0.000326	0.00382	CcSEcCtD
Cyproheptadine—Fatigue—Phentermine—obesity	0.000322	0.00377	CcSEcCtD
Cyproheptadine—Nasal congestion—Bupropion—obesity	0.000322	0.00377	CcSEcCtD
Cyproheptadine—Feeling abnormal—Phenylpropanolamine—obesity	0.000322	0.00377	CcSEcCtD
Cyproheptadine—Urinary retention—Sibutramine—obesity	0.00032	0.00374	CcSEcCtD
Cyproheptadine—Constipation—Phentermine—obesity	0.00032	0.00374	CcSEcCtD
Cyproheptadine—Tachycardia—Diethylpropion—obesity	0.000318	0.00372	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Diethylpropion—obesity	0.000315	0.00368	CcSEcCtD
Cyproheptadine—Headache—Benzphetamine—obesity	0.000314	0.00368	CcSEcCtD
Cyproheptadine—HRH1—respiratory system—obesity	0.000314	0.0128	CbGeAlD
Cyproheptadine—Diarrhoea—Phendimetrazine—obesity	0.000313	0.00366	CcSEcCtD
Cyproheptadine—HTR2B—digestive system—obesity	0.000312	0.0127	CbGeAlD
Cyproheptadine—Increased appetite—Bupropion—obesity	0.000312	0.00365	CcSEcCtD
Cyproheptadine—Confusional state—Cimetidine—obesity	0.000312	0.00365	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Cimetidine—obesity	0.000303	0.00355	CcSEcCtD
Cyproheptadine—Dizziness—Phendimetrazine—obesity	0.000303	0.00354	CcSEcCtD
Cyproheptadine—Tachycardia—Cimetidine—obesity	0.000302	0.00354	CcSEcCtD
Cyproheptadine—CHRM3—adipose tissue—obesity	0.000298	0.0122	CbGeAlD
Cyproheptadine—Nausea—Benzphetamine—obesity	0.000298	0.00349	CcSEcCtD
Cyproheptadine—HTR2B—adrenal gland—obesity	0.000298	0.0121	CbGeAlD
Cyproheptadine—Urticaria—Phentermine—obesity	0.000297	0.00348	CcSEcCtD
Cyproheptadine—Insomnia—Diethylpropion—obesity	0.000294	0.00344	CcSEcCtD
Cyproheptadine—Diplopia—Bupropion—obesity	0.000293	0.00343	CcSEcCtD
Cyproheptadine—Sweating increased—Orlistat—obesity	0.000293	0.00343	CcSEcCtD
Cyproheptadine—Somnolence—Diethylpropion—obesity	0.000289	0.00338	CcSEcCtD
Cyproheptadine—Headache—Phendimetrazine—obesity	0.000287	0.00335	CcSEcCtD
Cyproheptadine—Dyspepsia—Diethylpropion—obesity	0.000286	0.00335	CcSEcCtD
Cyproheptadine—CHRM2—endocrine gland—obesity	0.000285	0.0116	CbGeAlD
Cyproheptadine—CHRM3—digestive system—obesity	0.000281	0.0115	CbGeAlD
Cyproheptadine—Irritability—Bupropion—obesity	0.00028	0.00328	CcSEcCtD
Cyproheptadine—Urinary retention—Bupropion—obesity	0.000279	0.00326	CcSEcCtD
Cyproheptadine—Constipation—Diethylpropion—obesity	0.000278	0.00326	CcSEcCtD
Cyproheptadine—Somnolence—Cimetidine—obesity	0.000275	0.00322	CcSEcCtD
Cyproheptadine—Nausea—Phendimetrazine—obesity	0.000272	0.00318	CcSEcCtD
Cyproheptadine—DRD2—pituitary gland—obesity	0.00027	0.011	CbGeAlD
Cyproheptadine—Pollakiuria—Sibutramine—obesity	0.000269	0.00314	CcSEcCtD
Cyproheptadine—Asthenia—Phentermine—obesity	0.000268	0.00314	CcSEcCtD
Cyproheptadine—Feeling abnormal—Diethylpropion—obesity	0.000268	0.00314	CcSEcCtD
Cyproheptadine—Fatigue—Cimetidine—obesity	0.000267	0.00312	CcSEcCtD
Cyproheptadine—HTR1A—adrenal gland—obesity	0.000267	0.0109	CbGeAlD
Cyproheptadine—Photosensitivity reaction—Sibutramine—obesity	0.000265	0.00311	CcSEcCtD
Cyproheptadine—Constipation—Cimetidine—obesity	0.000265	0.0031	CcSEcCtD
Cyproheptadine—Weight increased—Sibutramine—obesity	0.000265	0.0031	CcSEcCtD
Cyproheptadine—SLC6A2—adrenal gland—obesity	0.000264	0.0108	CbGeAlD
Cyproheptadine—Neuropathy peripheral—Orlistat—obesity	0.000263	0.00307	CcSEcCtD
Cyproheptadine—HTR2A—respiratory system—obesity	0.000262	0.0107	CbGeAlD
Cyproheptadine—CHRM1—endocrine gland—obesity	0.000259	0.0106	CbGeAlD
Cyproheptadine—Urticaria—Diethylpropion—obesity	0.000258	0.00302	CcSEcCtD
Cyproheptadine—Dizziness—Phenylpropanolamine—obesity	0.000258	0.00302	CcSEcCtD
Cyproheptadine—Diarrhoea—Phentermine—obesity	0.000256	0.00299	CcSEcCtD
Cyproheptadine—Feeling abnormal—Cimetidine—obesity	0.000255	0.00298	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Sibutramine—obesity	0.000254	0.00297	CcSEcCtD
Cyproheptadine—Vomiting—Phenylpropanolamine—obesity	0.000248	0.00291	CcSEcCtD
Cyproheptadine—Dizziness—Phentermine—obesity	0.000247	0.00289	CcSEcCtD
Cyproheptadine—Sweating increased—Bupropion—obesity	0.000247	0.00289	CcSEcCtD
Cyproheptadine—Rash—Phenylpropanolamine—obesity	0.000246	0.00288	CcSEcCtD
Cyproheptadine—Dermatitis—Phenylpropanolamine—obesity	0.000246	0.00288	CcSEcCtD
Cyproheptadine—Hepatitis—Orlistat—obesity	0.000241	0.00281	CcSEcCtD
Cyproheptadine—Vomiting—Phentermine—obesity	0.000238	0.00278	CcSEcCtD
Cyproheptadine—Rash—Phentermine—obesity	0.000236	0.00276	CcSEcCtD
Cyproheptadine—Dermatitis—Phentermine—obesity	0.000236	0.00276	CcSEcCtD
Cyproheptadine—Headache—Phentermine—obesity	0.000234	0.00274	CcSEcCtD
Cyproheptadine—Pollakiuria—Bupropion—obesity	0.000234	0.00274	CcSEcCtD
Cyproheptadine—CHRM3—endocrine gland—obesity	0.000232	0.00948	CbGeAlD
Cyproheptadine—Nausea—Phenylpropanolamine—obesity	0.000232	0.00272	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Bupropion—obesity	0.000231	0.00271	CcSEcCtD
Cyproheptadine—HTR1A—endocrine gland—obesity	0.000231	0.00944	CbGeAlD
Cyproheptadine—Weight increased—Bupropion—obesity	0.000231	0.0027	CcSEcCtD
Cyproheptadine—SLC6A2—endocrine gland—obesity	0.000229	0.00936	CbGeAlD
Cyproheptadine—Diarrhoea—Diethylpropion—obesity	0.000223	0.0026	CcSEcCtD
Cyproheptadine—Nausea—Phentermine—obesity	0.000222	0.0026	CcSEcCtD
Cyproheptadine—Asthenia—Cimetidine—obesity	0.000222	0.0026	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Bupropion—obesity	0.000222	0.00259	CcSEcCtD
Cyproheptadine—Euphoric mood—Topiramate—obesity	0.000221	0.00259	CcSEcCtD
Cyproheptadine—Jaundice—Bupropion—obesity	0.00022	0.00258	CcSEcCtD
Cyproheptadine—Tinnitus—Sibutramine—obesity	0.000217	0.00254	CcSEcCtD
Cyproheptadine—Dizziness—Diethylpropion—obesity	0.000215	0.00252	CcSEcCtD
Cyproheptadine—Amitriptyline—NTRK2—obesity	0.000213	0.094	CrCbGaD
Cyproheptadine—HRH1—adipose tissue—obesity	0.000212	0.00866	CbGeAlD
Cyproheptadine—Diarrhoea—Cimetidine—obesity	0.000212	0.00248	CcSEcCtD
Cyproheptadine—DRD2—endocrine gland—obesity	0.000209	0.00853	CbGeAlD
Cyproheptadine—Chills—Sibutramine—obesity	0.000209	0.00244	CcSEcCtD
Cyproheptadine—Hepatic failure—Topiramate—obesity	0.000208	0.00243	CcSEcCtD
Cyproheptadine—Vomiting—Diethylpropion—obesity	0.000207	0.00242	CcSEcCtD
Cyproheptadine—Nasal congestion—Topiramate—obesity	0.000205	0.0024	CcSEcCtD
Cyproheptadine—Rash—Diethylpropion—obesity	0.000205	0.0024	CcSEcCtD
Cyproheptadine—Dermatitis—Diethylpropion—obesity	0.000205	0.0024	CcSEcCtD
Cyproheptadine—Dizziness—Cimetidine—obesity	0.000205	0.0024	CcSEcCtD
Cyproheptadine—Headache—Diethylpropion—obesity	0.000204	0.00238	CcSEcCtD
Cyproheptadine—Hepatitis—Bupropion—obesity	0.000203	0.00237	CcSEcCtD
Cyproheptadine—Hallucination—Bupropion—obesity	0.000202	0.00236	CcSEcCtD
Cyproheptadine—HTR2A—cardiovascular system—obesity	0.000201	0.0082	CbGeAlD
Cyproheptadine—HRH1—digestive system—obesity	0.0002	0.00815	CbGeAlD
Cyproheptadine—Increased appetite—Topiramate—obesity	0.000199	0.00233	CcSEcCtD
Cyproheptadine—Tension—Sibutramine—obesity	0.000199	0.00233	CcSEcCtD
Cyproheptadine—Vision blurred—Orlistat—obesity	0.000197	0.00231	CcSEcCtD
Cyproheptadine—Nervousness—Sibutramine—obesity	0.000197	0.0023	CcSEcCtD
Cyproheptadine—Vomiting—Cimetidine—obesity	0.000197	0.0023	CcSEcCtD
Cyproheptadine—Rash—Cimetidine—obesity	0.000195	0.00228	CcSEcCtD
Cyproheptadine—Dermatitis—Cimetidine—obesity	0.000195	0.00228	CcSEcCtD
Cyproheptadine—Headache—Cimetidine—obesity	0.000194	0.00227	CcSEcCtD
Cyproheptadine—Nausea—Diethylpropion—obesity	0.000193	0.00226	CcSEcCtD
Cyproheptadine—Vision blurred—Sibutramine—obesity	0.000191	0.00223	CcSEcCtD
Cyproheptadine—HRH1—adrenal gland—obesity	0.00019	0.00777	CbGeAlD
Cyproheptadine—Tremor—Sibutramine—obesity	0.00019	0.00222	CcSEcCtD
Cyproheptadine—Tinnitus—Bupropion—obesity	0.000189	0.00221	CcSEcCtD
Cyproheptadine—Vertigo—Orlistat—obesity	0.000188	0.0022	CcSEcCtD
Cyproheptadine—Diplopia—Topiramate—obesity	0.000187	0.00219	CcSEcCtD
Cyproheptadine—Agitation—Sibutramine—obesity	0.000186	0.00218	CcSEcCtD
Cyproheptadine—Palpitations—Orlistat—obesity	0.000185	0.00217	CcSEcCtD
Cyproheptadine—Nausea—Cimetidine—obesity	0.000184	0.00215	CcSEcCtD
Cyproheptadine—Chills—Bupropion—obesity	0.000182	0.00213	CcSEcCtD
Cyproheptadine—Vertigo—Sibutramine—obesity	0.000182	0.00213	CcSEcCtD
Cyproheptadine—Syncope—Sibutramine—obesity	0.000182	0.00213	CcSEcCtD
Cyproheptadine—Convulsion—Orlistat—obesity	0.000181	0.00212	CcSEcCtD
Cyproheptadine—Leukopenia—Sibutramine—obesity	0.000181	0.00212	CcSEcCtD
Cyproheptadine—Palpitations—Sibutramine—obesity	0.000179	0.0021	CcSEcCtD
Cyproheptadine—Irritability—Topiramate—obesity	0.000178	0.00209	CcSEcCtD
Cyproheptadine—Loss of consciousness—Sibutramine—obesity	0.000178	0.00208	CcSEcCtD
Cyproheptadine—HTR2A—pituitary gland—obesity	0.000178	0.00726	CbGeAlD
Cyproheptadine—Urinary retention—Topiramate—obesity	0.000178	0.00208	CcSEcCtD
Cyproheptadine—Convulsion—Sibutramine—obesity	0.000176	0.00205	CcSEcCtD
Cyproheptadine—Tension—Bupropion—obesity	0.000173	0.00203	CcSEcCtD
Cyproheptadine—Nervousness—Bupropion—obesity	0.000172	0.00201	CcSEcCtD
Cyproheptadine—Oedema—Orlistat—obesity	0.000171	0.002	CcSEcCtD
Cyproheptadine—Confusional state—Sibutramine—obesity	0.000167	0.00195	CcSEcCtD
Cyproheptadine—HTR2A—digestive system—obesity	0.000167	0.00681	CbGeAlD
Cyproheptadine—Vision blurred—Bupropion—obesity	0.000167	0.00195	CcSEcCtD
Cyproheptadine—Tremor—Bupropion—obesity	0.000166	0.00194	CcSEcCtD
Cyproheptadine—Oedema—Sibutramine—obesity	0.000165	0.00194	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Orlistat—obesity	0.000165	0.00193	CcSEcCtD
Cyproheptadine—HRH1—endocrine gland—obesity	0.000165	0.00673	CbGeAlD
Cyproheptadine—Shock—Sibutramine—obesity	0.000163	0.0019	CcSEcCtD
Cyproheptadine—Agitation—Bupropion—obesity	0.000162	0.0019	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Sibutramine—obesity	0.000162	0.00189	CcSEcCtD
Cyproheptadine—Tachycardia—Sibutramine—obesity	0.000161	0.00189	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Sibutramine—obesity	0.00016	0.00187	CcSEcCtD
Cyproheptadine—HTR2A—adrenal gland—obesity	0.000159	0.00649	CbGeAlD
Cyproheptadine—Vertigo—Bupropion—obesity	0.000159	0.00186	CcSEcCtD
Cyproheptadine—Syncope—Bupropion—obesity	0.000158	0.00185	CcSEcCtD
Cyproheptadine—Leukopenia—Bupropion—obesity	0.000158	0.00185	CcSEcCtD
Cyproheptadine—Anorexia—Sibutramine—obesity	0.000158	0.00184	CcSEcCtD
Cyproheptadine—Sweating increased—Topiramate—obesity	0.000157	0.00184	CcSEcCtD
Cyproheptadine—Palpitations—Bupropion—obesity	0.000156	0.00183	CcSEcCtD
Cyproheptadine—Loss of consciousness—Bupropion—obesity	0.000155	0.00182	CcSEcCtD
Cyproheptadine—Insomnia—Orlistat—obesity	0.000155	0.00181	CcSEcCtD
Cyproheptadine—Hypotension—Sibutramine—obesity	0.000155	0.00181	CcSEcCtD
Cyproheptadine—Paraesthesia—Orlistat—obesity	0.000153	0.0018	CcSEcCtD
Cyproheptadine—Convulsion—Bupropion—obesity	0.000153	0.00179	CcSEcCtD
Cyproheptadine—Dyspepsia—Orlistat—obesity	0.00015	0.00176	CcSEcCtD
Cyproheptadine—Insomnia—Sibutramine—obesity	0.00015	0.00175	CcSEcCtD
Cyproheptadine—Pollakiuria—Topiramate—obesity	0.000149	0.00175	CcSEcCtD
Cyproheptadine—Decreased appetite—Orlistat—obesity	0.000149	0.00174	CcSEcCtD
Cyproheptadine—Paraesthesia—Sibutramine—obesity	0.000149	0.00174	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Topiramate—obesity	0.000147	0.00173	CcSEcCtD
Cyproheptadine—Fatigue—Orlistat—obesity	0.000147	0.00172	CcSEcCtD
Cyproheptadine—Somnolence—Sibutramine—obesity	0.000147	0.00172	CcSEcCtD
Cyproheptadine—Weight increased—Topiramate—obesity	0.000147	0.00172	CcSEcCtD
Cyproheptadine—Dyspepsia—Sibutramine—obesity	0.000146	0.0017	CcSEcCtD
Cyproheptadine—Confusional state—Bupropion—obesity	0.000145	0.0017	CcSEcCtD
Cyproheptadine—Oedema—Bupropion—obesity	0.000144	0.00169	CcSEcCtD
Cyproheptadine—Decreased appetite—Sibutramine—obesity	0.000144	0.00168	CcSEcCtD
Cyproheptadine—Shock—Bupropion—obesity	0.000142	0.00166	CcSEcCtD
Cyproheptadine—Constipation—Sibutramine—obesity	0.000141	0.00165	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Topiramate—obesity	0.000141	0.00165	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Bupropion—obesity	0.000141	0.00165	CcSEcCtD
Cyproheptadine—Feeling abnormal—Orlistat—obesity	0.000141	0.00165	CcSEcCtD
Cyproheptadine—Tachycardia—Bupropion—obesity	0.000141	0.00165	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Bupropion—obesity	0.000139	0.00163	CcSEcCtD
Cyproheptadine—Protriptyline—SLC6A4—obesity	0.000138	0.061	CrCbGaD
Cyproheptadine—HTR2A—endocrine gland—obesity	0.000138	0.00562	CbGeAlD
Cyproheptadine—Anorexia—Bupropion—obesity	0.000137	0.00161	CcSEcCtD
Cyproheptadine—Feeling abnormal—Sibutramine—obesity	0.000136	0.00159	CcSEcCtD
Cyproheptadine—Urticaria—Orlistat—obesity	0.000136	0.00159	CcSEcCtD
Cyproheptadine—Hypotension—Bupropion—obesity	0.000135	0.00158	CcSEcCtD
Cyproheptadine—Agranulocytosis—Topiramate—obesity	0.000134	0.00157	CcSEcCtD
Cyproheptadine—Clozapine—HRH3—obesity	0.000133	0.0587	CrCbGaD
Cyproheptadine—Urticaria—Sibutramine—obesity	0.000131	0.00154	CcSEcCtD
Cyproheptadine—Insomnia—Bupropion—obesity	0.00013	0.00153	CcSEcCtD
Cyproheptadine—Paraesthesia—Bupropion—obesity	0.000129	0.00151	CcSEcCtD
Cyproheptadine—Hepatitis—Topiramate—obesity	0.000129	0.00151	CcSEcCtD
Cyproheptadine—Hallucination—Topiramate—obesity	0.000129	0.00151	CcSEcCtD
Cyproheptadine—Somnolence—Bupropion—obesity	0.000128	0.0015	CcSEcCtD
Cyproheptadine—Dyspepsia—Bupropion—obesity	0.000127	0.00149	CcSEcCtD
Cyproheptadine—Decreased appetite—Bupropion—obesity	0.000125	0.00147	CcSEcCtD
Cyproheptadine—Metixene—HTR2C—obesity	0.000125	0.055	CrCbGaD
Cyproheptadine—Fatigue—Bupropion—obesity	0.000124	0.00145	CcSEcCtD
Cyproheptadine—HTR2A—liver—obesity	0.000124	0.00507	CbGeAlD
Cyproheptadine—Constipation—Bupropion—obesity	0.000123	0.00144	CcSEcCtD
Cyproheptadine—Asthenia—Orlistat—obesity	0.000123	0.00143	CcSEcCtD
Cyproheptadine—Tinnitus—Topiramate—obesity	0.000121	0.00141	CcSEcCtD
Cyproheptadine—Feeling abnormal—Bupropion—obesity	0.000119	0.00139	CcSEcCtD
Cyproheptadine—Asthenia—Sibutramine—obesity	0.000119	0.00139	CcSEcCtD
Cyproheptadine—Diarrhoea—Orlistat—obesity	0.000117	0.00137	CcSEcCtD
Cyproheptadine—Chills—Topiramate—obesity	0.000116	0.00136	CcSEcCtD
Cyproheptadine—Urticaria—Bupropion—obesity	0.000115	0.00134	CcSEcCtD
Cyproheptadine—Diarrhoea—Sibutramine—obesity	0.000113	0.00132	CcSEcCtD
Cyproheptadine—Dizziness—Orlistat—obesity	0.000113	0.00132	CcSEcCtD
Cyproheptadine—Tension—Topiramate—obesity	0.00011	0.00129	CcSEcCtD
Cyproheptadine—Dizziness—Sibutramine—obesity	0.000109	0.00128	CcSEcCtD
Cyproheptadine—Nervousness—Topiramate—obesity	0.000109	0.00128	CcSEcCtD
Cyproheptadine—Vomiting—Orlistat—obesity	0.000109	0.00127	CcSEcCtD
Cyproheptadine—Rash—Orlistat—obesity	0.000108	0.00126	CcSEcCtD
Cyproheptadine—Dermatitis—Orlistat—obesity	0.000108	0.00126	CcSEcCtD
Cyproheptadine—Headache—Orlistat—obesity	0.000107	0.00125	CcSEcCtD
Cyproheptadine—Vision blurred—Topiramate—obesity	0.000106	0.00124	CcSEcCtD
Cyproheptadine—Tremor—Topiramate—obesity	0.000105	0.00123	CcSEcCtD
Cyproheptadine—Vomiting—Sibutramine—obesity	0.000105	0.00123	CcSEcCtD
Cyproheptadine—Rash—Sibutramine—obesity	0.000104	0.00122	CcSEcCtD
Cyproheptadine—Dermatitis—Sibutramine—obesity	0.000104	0.00122	CcSEcCtD
Cyproheptadine—Headache—Sibutramine—obesity	0.000104	0.00121	CcSEcCtD
Cyproheptadine—Asthenia—Bupropion—obesity	0.000103	0.00121	CcSEcCtD
Cyproheptadine—Agitation—Topiramate—obesity	0.000103	0.00121	CcSEcCtD
Cyproheptadine—Nausea—Orlistat—obesity	0.000102	0.00119	CcSEcCtD
Cyproheptadine—Vertigo—Topiramate—obesity	0.000101	0.00118	CcSEcCtD
Cyproheptadine—Syncope—Topiramate—obesity	0.000101	0.00118	CcSEcCtD
Cyproheptadine—Leukopenia—Topiramate—obesity	0.000101	0.00118	CcSEcCtD
Cyproheptadine—Palpitations—Topiramate—obesity	9.95e-05	0.00116	CcSEcCtD
Cyproheptadine—Loss of consciousness—Topiramate—obesity	9.89e-05	0.00116	CcSEcCtD
Cyproheptadine—Diarrhoea—Bupropion—obesity	9.87e-05	0.00115	CcSEcCtD
Cyproheptadine—Nausea—Sibutramine—obesity	9.82e-05	0.00115	CcSEcCtD
Cyproheptadine—Convulsion—Topiramate—obesity	9.75e-05	0.00114	CcSEcCtD
Cyproheptadine—Dizziness—Bupropion—obesity	9.53e-05	0.00112	CcSEcCtD
Cyproheptadine—Confusional state—Topiramate—obesity	9.26e-05	0.00108	CcSEcCtD
Cyproheptadine—Oedema—Topiramate—obesity	9.19e-05	0.00107	CcSEcCtD
Cyproheptadine—Vomiting—Bupropion—obesity	9.17e-05	0.00107	CcSEcCtD
Cyproheptadine—Rash—Bupropion—obesity	9.09e-05	0.00106	CcSEcCtD
Cyproheptadine—Dermatitis—Bupropion—obesity	9.08e-05	0.00106	CcSEcCtD
Cyproheptadine—Shock—Topiramate—obesity	9.04e-05	0.00106	CcSEcCtD
Cyproheptadine—Headache—Bupropion—obesity	9.03e-05	0.00106	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Topiramate—obesity	8.99e-05	0.00105	CcSEcCtD
Cyproheptadine—Tachycardia—Topiramate—obesity	8.97e-05	0.00105	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Topiramate—obesity	8.88e-05	0.00104	CcSEcCtD
Cyproheptadine—Anorexia—Topiramate—obesity	8.76e-05	0.00102	CcSEcCtD
Cyproheptadine—Hypotension—Topiramate—obesity	8.58e-05	0.001	CcSEcCtD
Cyproheptadine—Nausea—Bupropion—obesity	8.56e-05	0.001	CcSEcCtD
Cyproheptadine—Insomnia—Topiramate—obesity	8.31e-05	0.000972	CcSEcCtD
Cyproheptadine—Paraesthesia—Topiramate—obesity	8.25e-05	0.000965	CcSEcCtD
Cyproheptadine—Somnolence—Topiramate—obesity	8.17e-05	0.000956	CcSEcCtD
Cyproheptadine—Dyspepsia—Topiramate—obesity	8.09e-05	0.000946	CcSEcCtD
Cyproheptadine—Decreased appetite—Topiramate—obesity	7.99e-05	0.000934	CcSEcCtD
Cyproheptadine—Cyclobenzaprine—HTR2A—obesity	7.93e-05	0.035	CrCbGaD
Cyproheptadine—Fatigue—Topiramate—obesity	7.92e-05	0.000927	CcSEcCtD
Cyproheptadine—Constipation—Topiramate—obesity	7.86e-05	0.000919	CcSEcCtD
Cyproheptadine—Loxapine—DRD4—obesity	7.85e-05	0.0346	CrCbGaD
Cyproheptadine—Feeling abnormal—Topiramate—obesity	7.57e-05	0.000886	CcSEcCtD
Cyproheptadine—Urticaria—Topiramate—obesity	7.3e-05	0.000854	CcSEcCtD
Cyproheptadine—Mianserin—HTR2C—obesity	7.15e-05	0.0316	CrCbGaD
Cyproheptadine—Loxapine—HTR1B—obesity	6.97e-05	0.0308	CrCbGaD
Cyproheptadine—Loxapine—DRD1—obesity	6.64e-05	0.0293	CrCbGaD
Cyproheptadine—Asthenia—Topiramate—obesity	6.59e-05	0.000771	CcSEcCtD
Cyproheptadine—Clozapine—DRD4—obesity	6.59e-05	0.0291	CrCbGaD
Cyproheptadine—Nortriptyline—HTR2C—obesity	6.39e-05	0.0282	CrCbGaD
Cyproheptadine—Diarrhoea—Topiramate—obesity	6.29e-05	0.000735	CcSEcCtD
Cyproheptadine—Loxapine—ADRB1—obesity	6.17e-05	0.0272	CrCbGaD
Cyproheptadine—Dizziness—Topiramate—obesity	6.07e-05	0.000711	CcSEcCtD
Cyproheptadine—Mianserin—SLC6A4—obesity	5.93e-05	0.0262	CrCbGaD
Cyproheptadine—Mianserin—DRD2—obesity	5.9e-05	0.026	CrCbGaD
Cyproheptadine—Clozapine—HTR1B—obesity	5.85e-05	0.0258	CrCbGaD
Cyproheptadine—Vomiting—Topiramate—obesity	5.84e-05	0.000683	CcSEcCtD
Cyproheptadine—Rash—Topiramate—obesity	5.79e-05	0.000678	CcSEcCtD
Cyproheptadine—Dermatitis—Topiramate—obesity	5.79e-05	0.000677	CcSEcCtD
Cyproheptadine—Headache—Topiramate—obesity	5.75e-05	0.000673	CcSEcCtD
Cyproheptadine—Loxapine—HTR2C—obesity	5.68e-05	0.0251	CrCbGaD
Cyproheptadine—Clozapine—DRD1—obesity	5.58e-05	0.0246	CrCbGaD
Cyproheptadine—Nausea—Topiramate—obesity	5.46e-05	0.000638	CcSEcCtD
Cyproheptadine—Amitriptyline—HTR1B—obesity	5.44e-05	0.024	CrCbGaD
Cyproheptadine—Nortriptyline—SLC6A4—obesity	5.3e-05	0.0234	CrCbGaD
Cyproheptadine—Nortriptyline—DRD2—obesity	5.27e-05	0.0233	CrCbGaD
Cyproheptadine—Nortriptyline—CYP2E1—obesity	5.07e-05	0.0224	CrCbGaD
Cyproheptadine—Clozapine—HTR2C—obesity	4.77e-05	0.0211	CrCbGaD
Cyproheptadine—Loxapine—SLC6A4—obesity	4.71e-05	0.0208	CrCbGaD
Cyproheptadine—Loxapine—DRD2—obesity	4.68e-05	0.0207	CrCbGaD
Cyproheptadine—Mianserin—HTR2A—obesity	4.56e-05	0.0201	CrCbGaD
Cyproheptadine—Amitriptyline—HTR2C—obesity	4.44e-05	0.0196	CrCbGaD
Cyproheptadine—Nortriptyline—HTR2A—obesity	4.07e-05	0.018	CrCbGaD
Cyproheptadine—Clozapine—DRD2—obesity	3.93e-05	0.0174	CrCbGaD
Cyproheptadine—Clozapine—CYP2E1—obesity	3.78e-05	0.0167	CrCbGaD
Cyproheptadine—Amitriptyline—SLC6A4—obesity	3.68e-05	0.0162	CrCbGaD
Cyproheptadine—Amitriptyline—DRD2—obesity	3.66e-05	0.0161	CrCbGaD
Cyproheptadine—Loxapine—HTR2A—obesity	3.62e-05	0.016	CrCbGaD
Cyproheptadine—Amitriptyline—CYP2E1—obesity	3.52e-05	0.0155	CrCbGaD
Cyproheptadine—Clozapine—HTR2A—obesity	3.04e-05	0.0134	CrCbGaD
Cyproheptadine—Amitriptyline—HTR2A—obesity	2.83e-05	0.0125	CrCbGaD
Cyproheptadine—Nortriptyline—ALB—obesity	2.79e-05	0.0123	CrCbGaD
Cyproheptadine—Amitriptyline—ALB—obesity	1.93e-05	0.00853	CrCbGaD
Cyproheptadine—HTR6—Signaling Pathways—MMP9—obesity	1.64e-06	1.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—F2—obesity	1.64e-06	1.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PRKCB—obesity	1.64e-06	1.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ESR1—obesity	1.64e-06	1.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—F2—obesity	1.63e-06	1.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PRKCB—obesity	1.63e-06	1.98e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—BAD—obesity	1.63e-06	1.97e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—BAD—obesity	1.63e-06	1.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ALB—obesity	1.62e-06	1.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—BAD—obesity	1.62e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PRKCB—obesity	1.62e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—F2—obesity	1.62e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—BAD—obesity	1.62e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CD—obesity	1.61e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CG—obesity	1.6e-06	1.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKT1—obesity	1.6e-06	1.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—BAD—obesity	1.6e-06	1.94e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK8—obesity	1.6e-06	1.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CD—obesity	1.6e-06	1.94e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKT1—obesity	1.59e-06	1.93e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—PIK3CA—obesity	1.59e-06	1.93e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SERPINE1—obesity	1.59e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IRS1—obesity	1.59e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—PIK3CA—obesity	1.58e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SERPINE1—obesity	1.58e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CG—obesity	1.58e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—obesity	1.58e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CG—obesity	1.57e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CG—obesity	1.57e-06	1.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CG—obesity	1.56e-06	1.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IRS1—obesity	1.56e-06	1.89e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IRS1—obesity	1.56e-06	1.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3R1—obesity	1.55e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—NOS3—obesity	1.55e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IRS1—obesity	1.55e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CG—obesity	1.55e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IRS1—obesity	1.55e-06	1.87e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TYK2—obesity	1.54e-06	1.87e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TYK2—obesity	1.54e-06	1.86e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—RHOA—obesity	1.53e-06	1.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IRS1—obesity	1.53e-06	1.86e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—POMC—obesity	1.53e-06	1.85e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—RHOA—obesity	1.52e-06	1.85e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—INS—obesity	1.52e-06	1.84e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3R1—obesity	1.52e-06	1.84e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOS3—obesity	1.52e-06	1.84e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3R1—obesity	1.51e-06	1.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOS3—obesity	1.51e-06	1.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—POMC—obesity	1.5e-06	1.82e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—obesity	1.5e-06	1.82e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—POMC—obesity	1.5e-06	1.82e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—POMC—obesity	1.49e-06	1.81e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—INS—obesity	1.49e-06	1.81e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL2—obesity	1.49e-06	1.81e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—INS—obesity	1.49e-06	1.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—POMC—obesity	1.49e-06	1.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—INS—obesity	1.49e-06	1.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—INS—obesity	1.48e-06	1.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—POMC—obesity	1.47e-06	1.79e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL2—obesity	1.47e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1—obesity	1.47e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT2—obesity	1.47e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—INS—obesity	1.47e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL2—obesity	1.47e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL2—obesity	1.46e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—STAT3—obesity	1.46e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK8—obesity	1.46e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL2—obesity	1.46e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—obesity	1.45e-06	1.76e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1—obesity	1.44e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PIK3CA—obesity	1.44e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT2—obesity	1.44e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL2—obesity	1.44e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1—obesity	1.44e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT2—obesity	1.44e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1—obesity	1.44e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PIK3CA—obesity	1.44e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT2—obesity	1.44e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CB—obesity	1.43e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1—obesity	1.43e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT2—obesity	1.43e-06	1.73e-05	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—obesity	1.43e-06	1.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—obesity	1.42e-06	1.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1—obesity	1.42e-06	1.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT2—obesity	1.42e-06	1.72e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CD—obesity	1.41e-06	1.71e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CB—obesity	1.4e-06	1.7e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MTOR—obesity	1.4e-06	1.7e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—PIK3CA—obesity	1.4e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SERPINE1—obesity	1.39e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MTOR—obesity	1.39e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CB—obesity	1.39e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CD—obesity	1.39e-06	1.68e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CD—obesity	1.38e-06	1.68e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CD—obesity	1.38e-06	1.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CD—obesity	1.38e-06	1.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—PIK3CA—obesity	1.37e-06	1.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SERPINE1—obesity	1.37e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—PIK3CA—obesity	1.37e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SERPINE1—obesity	1.37e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	1.37e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SERPINE1—obesity	1.36e-06	1.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	1.36e-06	1.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CD—obesity	1.36e-06	1.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SERPINE1—obesity	1.36e-06	1.65e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—obesity	1.36e-06	1.65e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TYK2—obesity	1.36e-06	1.64e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—obesity	1.35e-06	1.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	1.35e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SERPINE1—obesity	1.35e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RHOA—obesity	1.35e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TYK2—obesity	1.33e-06	1.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—STAT3—obesity	1.33e-06	1.62e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TYK2—obesity	1.33e-06	1.61e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOS3—obesity	1.33e-06	1.61e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3R1—obesity	1.33e-06	1.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TYK2—obesity	1.33e-06	1.61e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RHOA—obesity	1.32e-06	1.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TYK2—obesity	1.32e-06	1.6e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RHOA—obesity	1.32e-06	1.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RHOA—obesity	1.32e-06	1.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RHOA—obesity	1.31e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TYK2—obesity	1.31e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3R1—obesity	1.31e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOS3—obesity	1.31e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOS3—obesity	1.31e-06	1.58e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3R1—obesity	1.31e-06	1.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOS3—obesity	1.3e-06	1.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3R1—obesity	1.3e-06	1.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RHOA—obesity	1.3e-06	1.57e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—obesity	1.3e-06	1.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3R1—obesity	1.3e-06	1.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOS3—obesity	1.3e-06	1.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—obesity	1.29e-06	1.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3R1—obesity	1.29e-06	1.56e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOS3—obesity	1.29e-06	1.56e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—obesity	1.28e-06	1.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—obesity	1.27e-06	1.54e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—obesity	1.27e-06	1.54e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—obesity	1.25e-06	1.51e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—obesity	1.25e-06	1.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—obesity	1.24e-06	1.5e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—obesity	1.24e-06	1.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—obesity	1.24e-06	1.5e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—obesity	1.24e-06	1.5e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CB—obesity	1.23e-06	1.49e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MTOR—obesity	1.23e-06	1.49e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—obesity	1.23e-06	1.48e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—obesity	1.22e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—obesity	1.21e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MTOR—obesity	1.21e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CB—obesity	1.21e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CB—obesity	1.21e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MTOR—obesity	1.21e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MTOR—obesity	1.2e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CB—obesity	1.2e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CB—obesity	1.2e-06	1.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MTOR—obesity	1.2e-06	1.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CB—obesity	1.19e-06	1.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MTOR—obesity	1.19e-06	1.44e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK8—obesity	1.18e-06	1.43e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—obesity	1.18e-06	1.43e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK8—obesity	1.18e-06	1.43e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—obesity	1.17e-06	1.42e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—obesity	1.15e-06	1.4e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—obesity	1.14e-06	1.38e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—obesity	1.12e-06	1.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—obesity	1.12e-06	1.36e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—obesity	1.12e-06	1.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—obesity	1.12e-06	1.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—obesity	1.11e-06	1.35e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—obesity	1.1e-06	1.34e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—obesity	1.1e-06	1.34e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—obesity	1.1e-06	1.34e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—obesity	1.1e-06	1.33e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—obesity	1.1e-06	1.33e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—obesity	1.08e-06	1.31e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—obesity	1.08e-06	1.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—obesity	1.08e-06	1.3e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—obesity	1.07e-06	1.29e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—obesity	1.05e-06	1.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—obesity	1.05e-06	1.27e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—obesity	1.05e-06	1.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—obesity	1.05e-06	1.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—obesity	1.04e-06	1.26e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK8—obesity	1.04e-06	1.26e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—obesity	1.04e-06	1.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—obesity	1.03e-06	1.25e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK8—obesity	1.02e-06	1.24e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—obesity	1.02e-06	1.24e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK8—obesity	1.02e-06	1.24e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—obesity	1.02e-06	1.24e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—obesity	1.02e-06	1.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK8—obesity	1.02e-06	1.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—obesity	1.01e-06	1.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK8—obesity	1.01e-06	1.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—obesity	1.01e-06	1.22e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—obesity	1.01e-06	1.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK8—obesity	1e-06	1.22e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—obesity	1e-06	1.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—obesity	1e-06	1.21e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—obesity	1e-06	1.21e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—obesity	9.97e-07	1.21e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—obesity	9.5e-07	1.15e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—obesity	9.42e-07	1.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—obesity	9.34e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—obesity	9.32e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—obesity	9.32e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—obesity	9.29e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—obesity	9.26e-07	1.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—obesity	9.17e-07	1.11e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—obesity	8.82e-07	1.07e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—obesity	8.8e-07	1.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—obesity	8.74e-07	1.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—obesity	8.68e-07	1.05e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—obesity	8.66e-07	1.05e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—obesity	8.66e-07	1.05e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—obesity	8.64e-07	1.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—obesity	8.64e-07	1.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—obesity	8.62e-07	1.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—obesity	8.61e-07	1.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—obesity	8.59e-07	1.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—obesity	8.59e-07	1.04e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—obesity	8.53e-07	1.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—obesity	8.53e-07	1.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—obesity	8.5e-07	1.03e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—obesity	8.49e-07	1.03e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—obesity	7.56e-07	9.16e-06	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—obesity	7.52e-07	9.11e-06	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—obesity	7.49e-07	9.08e-06	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—obesity	7.37e-07	8.93e-06	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—obesity	7.35e-07	8.91e-06	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—obesity	7.33e-07	8.88e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—obesity	7.31e-07	8.86e-06	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—obesity	7.24e-07	8.77e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—obesity	7.14e-07	8.65e-06	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—obesity	6.97e-07	8.45e-06	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—obesity	6.93e-07	8.4e-06	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—obesity	6.63e-07	8.04e-06	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—obesity	6.53e-07	7.91e-06	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—obesity	6.51e-07	7.89e-06	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—obesity	6.49e-07	7.87e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—obesity	6.47e-07	7.84e-06	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—obesity	6.41e-07	7.77e-06	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—obesity	6.12e-07	7.42e-06	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—obesity	6.02e-07	7.3e-06	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—obesity	6.01e-07	7.28e-06	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—obesity	5.99e-07	7.26e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—obesity	5.97e-07	7.23e-06	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—obesity	5.91e-07	7.16e-06	CbGpPWpGaD
